NSE filing, NSE: CAPILLARY. Summary written from the filing by ALFA Finder's alert engine.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹528.10
- Market cap
- ₹4,203 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 99.9×Sector 22.9×
- Promoter holding
- 47.23%-4.22% QoQ
- FII holding
- 2.56%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Board Meeting Date
Capillary Technologies schedules a board meeting on 02 November 2026 to approve unaudited quarterly standalone and consolidated results. Trading window stays closed from 01 October to 04 November 2026.
Capillary Technologies India Management Change
Capillary Technologies India Limited appointed Mr. William Earl Swift as Senior Management Personnel overseeing operations across the Americas. Mr. Swift previously served as Brierley's CEO.
Capillary Technologies India Other Announcement
Capillary Technologies India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.
Capillary Technologies India Price Movement Clarification
Capillary Technologies clarified that recent stock price movement is market-driven and that the company has disclosed all material information as required by SEBI regulations.
Capillary Technologies India Capital Structure Change
Kotak Mahindra Mutual Fund acquired 93,281 shares of Capillary Technologies, crossing the 5% ownership threshold. No transaction value was disclosed in the Reg 29(1) filing.
Capillary Technologies India Capital Structure Change
Mirae Asset Mutual Fund decreased its shareholding in Capillary Technologies India Ltd by selling 1,75,842 shares. This disclosure was filed under SEBI SAST regulations.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.